Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
442.30M | 388.80M | 368.90M | 309.00M | 90.60M | 311.60M | Gross Profit |
64.40M | 181.50M | 172.80M | 140.90M | -14.60M | 147.10M | EBIT |
64.40M | 28.60M | 43.40M | 51.70M | -35.10M | 37.90M | EBITDA |
75.30M | 63.70M | 76.90M | 82.60M | -2.90M | 70.80M | Net Income Common Stockholders |
13.70M | 11.10M | 29.70M | 34.40M | -38.30M | 19.30M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.10M | 16.90M | 10.70M | 34.00M | 4.70M | 1.10M | Total Assets |
989.60M | 1.35B | 1.05B | 1.06B | 997.50M | 989.60M | Total Debt |
281.50M | 376.50M | 175.90M | 207.80M | 253.40M | 281.50M | Net Debt |
280.40M | 359.60M | 165.20M | 173.80M | 248.70M | 280.40M | Total Liabilities |
398.80M | 578.00M | 329.70M | 362.20M | 352.10M | 398.80M | Stockholders Equity |
590.80M | 771.60M | 724.20M | 699.70M | 645.40M | 590.80M |
Cash Flow | Free Cash Flow | ||||
28.80M | 24.90M | 42.70M | 65.00M | -42.10M | 26.10M | Operating Cash Flow |
74.80M | 73.40M | 82.90M | 101.90M | -23.00M | 59.00M | Investing Cash Flow |
-175.80M | -199.60M | -52.30M | -14.10M | -18.70M | -67.20M | Financing Cash Flow |
100.30M | 132.40M | -53.90M | -58.50M | 45.30M | 800.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | £1.65B | 9.83 | 6.90% | ― | 1.95% | 275.56% | |
74 Outperform | £325.43M | 12.51 | 6.45% | 2.49% | 2.22% | 98.79% | |
73 Outperform | £775.36M | 13.70 | 16.38% | 0.56% | 3.70% | 57.10% | |
72 Outperform | £43.34B | 37.79 | 21.77% | 3.06% | 7.67% | -15.09% | |
67 Neutral | £255.90M | 5.79 | 10.69% | ― | 0.50% | ― | |
62 Neutral | $6.82B | 11.05 | 2.80% | 4.32% | 2.67% | -24.92% | |
60 Neutral | £518.85M | 39.29 | 1.27% | 3.72% | 16.73% | -55.22% |